Progenics Pharmaceuticals (PGNX) Stock News
NASDAQ:PGNX - Nasdaq -
PGNX Latest News, Press Relases and Analysis
Lantheus files U.S. application for PET imaging agent for prostate cancer (NASDAQ:LNTH)
Lantheus Holdings (NASDAQ:LNTH), which merged with Progenics Pharmaceuticals (NASDAQ:PGNX) in June, announces the filing of a U.S.
Mentions: LNTH
ARLP, PGNX, AVDL and REZI among after-hours movers
Gainers: JFU +41%. CNST +10.6%. AVDL +4.1%CMCM +3.9%. PGNX +3%.Losers: BBGI -8.4%. NTN -6.4%. REZI -6.1%. LNTH -5.6%. ARLP -3.4%.
Independent Bank Group +6.4% on joining SmallCap 600 (NASDAQ:IBTX)
Independent Bank Group (NASDAQ:IBTX) is up 6.4% postmarket on word it's joining the S&P SmallCap 600 index. It's replacing Progenics Pharmaceuticals (NASDAQ:PGNX), which is set to be acquired by
Mentions: IBTX
The Daily Biotech Pulse: Patent Win For Amarin, FDA Nod For Novartis & Merck, Chembio's Coronavirus EUA Revoked
Here's a roundup of top developments in the biotech space over the last 24 hour. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) ADC Therapeutics SA (NYSE:...
Lantheus shareholders back stock issuance in Progenics tie-up (NASDAQ:LNTH)
Lantheus Holdings (NASDAQ:LNTH) shareholders voted overwhelmingly in favor of issuing common stock related to its previously announced merger with Progenics Pharmaceuticals (NASDAQ:PGNX). 99% of the v
Mentions: LNTH
SHAREHOLDER ALERT: WeissLaw LLP Investigates Progenics Pharmaceuticals, Inc.
Mentions: LNTH
ACB, BSX, PGNX and FLXN among after-hours movers
Gainers: ACB +26.4%. SCVL +5.8%. PGNX +4.4%. EVLO +3.4%. OPRA +3.4%.Losers: SCPH -12.4%. GLPG -10.6%. FLXN -6.6%. BSX -4.2%. RUTH -4.1%.
Progenics Pharmaceuticals EPS beats by $0.03, misses on revenue (NASDAQ:PGNX)
Progenics Pharmaceuticals (NASDAQ:PGNX): Q1 GAAP EPS of -$0.19 beats by $0.03.Revenue of $6.25M (+46.0% Y/Y) misses by $1.65M.Press Release
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs May 6.) Adverum Biotechnologies Inc...
Faruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against Progenics Pharmaceuticals, Inc. (PGNX)
Progenics Pharmaceuticals Sets First Quarter 2020 Financial Results and Business Update Call for May 7
ADDING MULTIMEDIA Velan Capital Agrees to Support Merger of Lantheus and Progenics
Mentions: LNTH
Velan Capital Agrees to Support Merger of Lantheus and Progenics
Mentions: LNTH
Stocks to Buy When the Bear Market Is Finally Over
Ten stocks that fall by outsize amounts during liquidity crises, but then outperform the market when liquidity returns.
Progenics Pharmaceuticals EPS beats by $0.12, beats on revenue
Progenics Pharmaceuticals (NASDAQ:PGNX): Q4 GAAP EPS of -$0.13 beats by $0.12.Revenue of $15.13M (+367.0% Y/Y) beats by $6.58M.Shares -1.36% PM.Press Release
Best & Worst Performing Small Cap Stocks for February 20, 2020
TOCA – TOCA leads the way today as the best performing small cap stock, closing up 87.50%.
Progenics up 11% on improved merger terms with Lantheus
The boards of Lantheus Holdings (LNTH -0.5%) and Progenics Pharmaceuticals (PGNX +11.4%) have agreed to amend their merger agreement, first announced in October 2019.Progenics shareholders will now re
Mentions: LNTH
Lantheus and Progenics Agree to Amended Transaction Terms
Mentions: LNTH
Key events next week - healthcare
Noteworthy events during the week of January 19 - 25 for healthcare investors.TUESDAY (1/21): Generex Biotechnology (OTCQB:GNBT): Investor conference call to discuss stock sales by certain institution
